Paratek Pharms

PRTK NASDAQ
3.610
-0.060
-1.63%
After Hours: 3.610 0 0.00% 17:04 07/16 EDT
Open
3.690
Prev Close
3.670
High
3.710
Low
3.577
Volume
373.17K
Avg Vol (3M)
295.67K
52 Week High
12.30
52 Week Low
3.400
% Turnover
1.15%
Market Cap
117.02M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Paratek Pharms PRTK stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Paratek Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics based upon tetracycline chemistry. Its product candidates are the antibacterials omadacycline and sarecycline. Omadacycline is an antibiotic being developed for use as an empiric monotherapy option for patients suffering from serious, community-acquired bacterial infections. Sarecycline is a tetracycline-derived compound designed for use in the treatment of acne and rosacea. Its other product candidates are tetracycline-derived, molecular entities and are designed to utilize the recognized immune-modulation, anti-inflammatory and other beneficial properties of the tetracycline class. These research stage programs include product candidates for multiple sclerosis, spinal muscular atrophy, systemic inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel diseases.
MORE >

Recently

Name
Price
%Change